Medpace Holdings EBITDA Margin 2014-2025 | MEDP
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Medpace Holdings (MEDP) over the last 10 years. The current EBITDA margin for Medpace Holdings as of March 31, 2025 is .
| Medpace Holdings EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-03-31 | $2.16B | $0.49B | 22.48% |
| 2024-12-31 | $2.11B | $0.48B | 22.57% |
| 2024-09-30 | $2.07B | $0.44B | 21.11% |
| 2024-06-30 | $2.03B | $0.41B | 20.16% |
| 2024-03-31 | $1.96B | $0.38B | 19.47% |
| 2023-12-31 | $1.89B | $0.36B | 19.26% |
| 2023-09-30 | $1.78B | $0.35B | 19.71% |
| 2023-06-30 | $1.67B | $0.34B | 20.50% |
| 2023-03-31 | $1.56B | $0.32B | 20.73% |
| 2022-12-31 | $1.46B | $0.30B | 20.62% |
| 2022-09-30 | $1.38B | $0.28B | 20.36% |
| 2022-06-30 | $1.29B | $0.26B | 19.81% |
| 2022-03-31 | $1.21B | $0.24B | 19.52% |
| 2021-12-31 | $1.14B | $0.22B | 19.34% |
| 2021-09-30 | $1.09B | $0.22B | 20.11% |
| 2021-06-30 | $1.03B | $0.21B | 20.62% |
| 2021-03-31 | $0.96B | $0.20B | 20.84% |
| 2020-12-31 | $0.93B | $0.19B | 20.09% |
| 2020-09-30 | $0.90B | $0.17B | 18.64% |
| 2020-06-30 | $0.88B | $0.15B | 17.12% |
| 2020-03-31 | $0.89B | $0.16B | 17.62% |
| 2019-12-31 | $0.86B | $0.15B | 17.54% |
| 2019-09-30 | $0.82B | $0.15B | 18.23% |
| 2019-06-30 | $0.79B | $0.15B | 18.45% |
| 2019-03-31 | $0.74B | $0.14B | 18.46% |
| 2018-12-31 | $0.70B | $0.13B | 18.89% |
| 2018-09-30 | $0.63B | $0.11B | 17.76% |
| 2018-06-30 | $0.56B | $0.11B | 19.75% |
| 2018-03-31 | $0.49B | $0.11B | 21.30% |
| 2017-12-31 | $0.44B | $0.10B | 23.57% |
| 2017-09-30 | $0.43B | $0.11B | 26.16% |
| 2017-06-30 | $0.43B | $0.11B | 26.11% |
| 2017-03-31 | $0.43B | $0.11B | 26.34% |
| 2016-12-31 | $0.42B | $0.11B | 26.78% |
| 2016-06-30 | $0.30B | $0.06B | 21.48% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $9.208B | $2.109B |
| Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $141.524B | 26.54 |
| CVS Health (CVS) | United States | $81.417B | 10.12 |
| Elevance Health (ELV) | United States | $76.834B | 9.91 |
| Cencora (COR) | United States | $57.577B | 20.03 |
| DiDi Global (DIDIY) | China | $25.180B | 26.75 |
| Natera (NTRA) | United States | $21.599B | 0.00 |
| Labcorp Holdings (LH) | United States | $20.908B | 16.96 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.318B | 0.00 |
| CochLear (CHEOY) | Australia | $13.009B | 0.00 |
| Solventum (SOLV) | United States | $12.815B | 13.57 |
| ICON (ICLR) | Ireland | $12.075B | 11.23 |
| Revvity (RVTY) | United States | $11.607B | 19.97 |
| Viatris (VTRS) | United States | $10.727B | 3.69 |
| Avantor (AVTR) | United States | $9.009B | 13.09 |
| Sonic Healthcare (SKHHY) | Australia | $8.842B | 0.00 |
| HealthEquity (HQY) | United States | $8.418B | 36.87 |
| Charles River Laboratories (CRL) | United States | $7.762B | 15.21 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.052B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.840B | 28.50 |
| BrightSpring Health Services (BTSG) | United States | $3.571B | 32.76 |
| Sotera Health (SHC) | United States | $3.296B | 18.73 |
| Surgery Partners (SGRY) | United States | $2.880B | 37.45 |
| Alignment Healthcare (ALHC) | United States | $2.651B | 0.00 |
| Concentras Parent (CON) | United States | $2.593B | 14.98 |
| Organon (OGN) | United States | $2.550B | 2.71 |
| GeneDx Holdings (WGS) | United States | $2.351B | 90.54 |
| Ardent Health (ARDT) | United States | $2.073B | 8.84 |
| Progyny (PGNY) | United States | $2.012B | 44.28 |
| PACS (PACS) | United States | $1.966B | 0.00 |
| Premier (PINC) | United States | $1.750B | 13.28 |
| GoodRx Holdings (GDRX) | United States | $1.725B | 34.50 |
| Teladoc Health (TDOC) | United States | $1.451B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.316B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.131B | 8.60 |
| CareDx (CDNA) | United States | $1.115B | 17.41 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| Agilon Health (AGL) | United States | $0.931B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.848B | 291.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.791B | 7.41 |
| Nutex Health (NUTX) | United States | $0.645B | 9.76 |
| Embecta (EMBC) | United States | $0.606B | 4.08 |
| InnovAge Holding (INNV) | United States | $0.582B | 0.00 |
| SBC Medicals (SBC) | United States | $0.518B | 0.00 |
| LifeMD (LFMD) | United States | $0.514B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.487B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.473B | 10.65 |
| Omada Health (OMDA) | $0.452B | 0.00 | |
| So-Young (SY) | China | $0.430B | 0.00 |
| Enhabit (EHAB) | United States | $0.359B | 29.50 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.347B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.331B | 0.00 |
| Oncology Institute (TOI) | United States | $0.286B | 0.00 |
| Beauty Health (SKIN) | United States | $0.236B | 0.00 |
| DocGo (DCGO) | United States | $0.149B | 24.33 |
| Pheton Holdings (PTHL) | China | $0.142B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.104B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.078B | 0.00 |
| KindlyMD (NAKA) | United States | $0.073B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.060B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.056B | 0.00 |
| ModivCare (MODV) | United States | $0.047B | 0.00 |
| Biodesix (BDSX) | United States | $0.046B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.036B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.022B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.012B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| SeaStar Medical Holding (ICU) | United States | $0.006B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |